Trial Profile

Prospective, Phase II/III, Randomized Clinical Study to Compare BEGEDINA Versus "Conventional Treatment" for Treating Steroid Resistant Acute Graft-versus Host Disease

Status: Discontinued

Phase of Trial: Phase II/III

Latest Information Update: 06 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Begelomab (Primary)
Indications Graft-versus-host disease
Focus Therapeutic Use
Sponsors ADIENNE

Most Recent Events

08 Feb 2019 The trial has been completed in France, according to the European Clinical Trials Database record.
02 Feb 2019 The trial has been completed in Germany , according to the European Clinical Trials Database record.
20 Sep 2017 Status changed from active, no longer recruiting to discontinued.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com